SimX, the leader in virtual reality (VR) healthcare training, and Elevate Healthcare, formerly CAE Healthcare, a global leader in simulation-based education, are proud to announce

The poster titled ‘Point-of-Care Testing for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning on Non-invasive Signals’ was presented at the American College of Cardiology’s Annual Scientific Session (ACC.25) in Chicago on March 30, 2025.

Carsten Schroeder, President and CEO of Terumo Neuro, commented on this significant milestone: “The WEB device has set a new standard in aneurysm treatment and has been instrumental in our mission to drive game-changing impact in neurovascular care. With 15 years of proven clinical success, WEB continues to advance patient outcomes, reducing the need for multiple devices and lengthy procedures. As we celebrate this achievement, we remain committed to innovating alongside leading physicians worldwide to shape the future of neurovascular care.”

Dr. Lisa Anderson, President of Paragonix Technologies. “This achievement validates our technology’s safety and effectiveness while expanding our ability to serve patients and healthcare providers in critical transplant care across the world. With this approval and the support structure provided by Sweden-based Getinge, we are dedicated to setting new standards in organ preservation, advancing the future of transplantation, and making a global impact.”

Following weeks of in-hospital monitoring, the patient was the first in the world to be discharged from the hospital with the BiVACOR Total Artificial Heart as he awaited a heart transplant. After having the device for 105 days, a donor heart became available, and the patient received a heart transplant on March 6, 2025.